Compare CNTB & FNWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNTB | FNWD |
|---|---|---|
| Founded | 2012 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.7M | 147.7M |
| IPO Year | 2020 | 1996 |
| Metric | CNTB | FNWD |
|---|---|---|
| Price | $2.13 | $44.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $8.67 | ★ $37.50 |
| AVG Volume (30 Days) | ★ 487.0K | 21.3K |
| Earning Date | 08-13-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.51% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.52 |
| Revenue | ★ $64,000.00 | N/A |
| Revenue This Year | N/A | $17.40 |
| Revenue Next Year | N/A | $5.44 |
| P/E Ratio | ★ N/A | $85.31 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.23 | $27.12 |
| 52 Week High | $3.82 | $45.00 |
| Indicator | CNTB | FNWD |
|---|---|---|
| Relative Strength Index (RSI) | 42.50 | 80.03 |
| Support Level | $1.99 | $35.02 |
| Resistance Level | $2.64 | N/A |
| Average True Range (ATR) | 0.14 | 0.79 |
| MACD | -0.03 | 0.49 |
| Stochastic Oscillator | 11.97 | 90.83 |
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
Finward Bancorp is a bank holding company that engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Savings Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out throughout the United States. The Company operates as a single reportable segment that derives its revenue mainly from the business of banking.